High-avidity, high-IFNγ-producing CD8 T-cell responses following immune selection during HIV-1 infection

Immunology and Cell Biology

Volumn 90, Issue 2, 2012, Pages 224-234

  Keane, Niamh M ^a   Roberts, Steven G ^a   Almeida, Coral Ann M ^a   Krishnan, Tanya ^a   Chopra, Abha ^a   Demaine, Emma ^a   Laird, Rebecca ^a   Tschochner, Monika ^a   Carlson, Jonathan M ^b   Mallal, Simon ^a,c   Heckerman, David ^b   James, Ian ^a   John, Mina ^a,c  

^a MURDOCH UNIVERSITY   (Australia)

^b MICROSOFT RESEARCH   (United States)

^c ROYAL PERTH HOSPITAL   (Australia)

Author keywords

HIV; immune escape; T cell response

Indexed keywords

EPITOPE; GAMMA INTERFERON; INTERLEUKIN 2;

ALLELE; ANTIGEN RECOGNITION; ARTICLE; CD8+ T LYMPHOCYTE; CYTOKINE PRODUCTION; CYTOTOXICITY; GENE EXPRESSION; GENOTYPE; HLA SYSTEM; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MAJOR CLINICAL STUDY; MEMORY T LYMPHOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; SEROCONVERSION; VIRUS LOAD;

CD8-POSITIVE T-LYMPHOCYTES; EPITOPES, T-LYMPHOCYTE; HIV INFECTIONS; HIV-1; HLA ANTIGENS; HUMANS; INTERFERON-GAMMA; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES, CYTOTOXIC; VIRAL LOAD;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84857033049     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2011.34     Document Type: Article

References (79)

1. Koup RA, Safrit JT, Cao Y, Andrews CA, McLeod G, Borkowsky W et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol 1994; 68: 4650-4655. (Pubitemid 24183063)
2. Phillips RE, Rowland-Jones S, Nixon DF, Gotch FM, Edwards JP, Ogunlesi AO et al. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature 1991; 354: 453-459. (Pubitemid 21896855)
3. Goonetilleke N, Liu M, Salazar-Gonzalez JF, Ferrari G, Giorgi E, Ganusov V et al. The first T cell response to transmitted/founder virus contributes to the control of acute viraemia in HIV-1 infection. J Exp Med 2009; 206: 1253-1272.
4. Price DA, Goulder PJ, Klenerman P, Sewell AK, Easterbrook PJ, Troop M et al. Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. Proc Natl Acad Sci USA 1997; 94: 1890-1895. (Pubitemid 27113932)
5. Borrow P, Lewicki H, Wei X, Horwitz MS, Peffer N, Meyers H et al. Antiviral pressure exerted by HIV-1 specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nat Med 1997; 3: 205-211. (Pubitemid 27064706)
6. Liu Y, McNevin J, Cao J, Zhao H, Genowati I, Wong KS et al. Selection on the human immunodeficiency virus type 1 proteome following primary infection. J Virol 2006; 80: 9519-9529. (Pubitemid 44435628)
7. Goulder PJ, Phillips RE, Colbert RA, McAdam S, Ogg G, Nowak MA et al. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat Med 1997; 3: 212-217. (Pubitemid 27064707)
8. Kelleher AD, Long C, Holmes EC, Allen RL, Wilson J, Conlon C et al. Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses. J Exp Med 2001; 193: 375-385. (Pubitemid 32524520)
9. Leslie AJ, Pfafferott KJ, Chetty P, Draenert R, Addo MM, Feeney M et al. HIV evolution: CTL escape mutation and reversion after transmission. Nat Med 2004; 10: 282-289. (Pubitemid 38667619)
10. Draenert R, Le Gall S, Pfafferott KJ, Leslie AJ, Chetty P, Brander C et al. Immune selection for altered antigen processing leads to cytotoxic T lymphocyte escape in chronic HIV-1 infection. J Exp Med 2004; 199: 905-915. (Pubitemid 38481082)
11. Allen TM, Altfeld M, Yu XG, O'Sullivan KM, Lichterfeld M, Le Gall S et al. Selection, transmission, and reversion of an antigen-processing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infection. J Virol 2004; 78: 7069-7078. (Pubitemid 38781545)
12. Yokomaku Y, Miura H, Tomiyama H, Kawana-Tachikawa A, Takiguchi M, Kojima A et al. Impaired processing and presentation of cytotoxic-T-lymphocyte (CTL) epitopes are major escape mechanisms from CTL immune pressure in human immunodeficiency virus type 1 infection. J Virol 2004; 78: 1324-1332. (Pubitemid 38095842)
13. Karlsson AC, Iversen AKN, Chapman JM, de Oliviera T, Spotts G, McMichael AJ et al. Sequential broadening of CTL responses in early HIV-1 infection is associated with viral escape. PLoS One 2007; 2: e225.
14. Feeney ME, Tang Y, Roosevelt KA, Leslie AJ, McIntosh K, Karthas N et al. Immune escape precedes breakthrough human immunodeficiency virus type 1 viremia and broadening of the cytotoxic T-lymphocyte response in an HLA-B27-positive long-termnonprogressing child. J Virol 2004; 78: 8927-8930. (Pubitemid 39025159)
15. Moore CB, John M, James IR, Christiansen FT, Witt CS, Mallal SA. Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level. Science 2002; 296: 1439-1443. (Pubitemid 34553083)
16. Bhattacharya T, Daniels M, Heckerman D, Foley B, Frahm N, Kadie C et al. Founder effects in the assessment of HIV polymorphisms and HLA allele associations. Science 2007; 315: 1583-1586. (Pubitemid 46449476)
17. Brumme ZL, Brumme CJ, Heckerman D, Korber BT, Daniels M, Carlson J et al. Evidence of differential HLA class I-mediated viral evolution in functional and accessory/regulatory genes of HIV-1. PLoS Pathog 2007; 3: e94.
18. Erratum in: PLoS Pathog. 10: e121.
19. Brumme ZL, Tao I, Szeto S, Brumme CJ, Carlson JM, Chan D et al. Human leukocyte antigen-specific polymorphisms in HIV-1 Gag and their association with viral load in chronic untreated infection. AIDS 2008; 22: 1277-1286.
20. Rousseau CM, Daniels MG, Carlson JM, Kadie C, Crawford H, Prendergast A et al. HLA class-I driven evolution of human immunodeficiency virus type 1 subtype C proteome: immune escape and viral load. J Virol 2008; 82: 6434-6446. (Pubitemid 351875121)
21. Carlson JM, Brumme ZL, Rousseau CM, Brumme CJ, Matthews P, Kadie C et al. Phylogenetic dependency networks: inferring patterns of CTL escape and codon covariation in HIV-1 Gag. PLoS Comput Biol 2008; 4: e1000225.
22. Wang YE, Li B, Carlson JM, Streeck H, Gladden AD, Goodman R et al. Protective HLA class I alleles that restrict acute-phase CD8+ T-cell responses are associated with viral escape mutations located in highly conserved regions of human immunodeficiency virus type 1. J Virol 2009; 83: 1845-1855.
23. Brumme ZL, John M, Carlson JM, Brumme CJ, Chan D, Brockman MA et al. HLAassociated immune escape pathways in HIV-1 subtype B Gag, Pol and Nef Proteins. PLoS One 2009; 4: e6687.
24. Kawashima Y, Pfafferott K, Frater J, Matthews P, Payne R, Addo M et al. Adaptation of HIV-1 to human leukocyte antigen class 1. Nature 2009; 458: 641-645.
25. Avila-Rios S, Ormsby CE, Carlson JM, Valenzuela-Ponce H, Blanco-Heredia J, Garrido-Rodriguez D et al. Unique features of HLA-mediated HIV evolution in a Mexican cohort: a comparative study. Retrovirology 2009; 6: 72.
26. John M, Heckerman D, James I, Park LP, Carlson JM, Chopra A et al. Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class 1 molecules with common supertype motifs. J Immunol 2010; 184: 4368-4377.
27. Allen TM, Yu XG, Kalife ET, Reyor LL, Lichterfeld M, John M et al. De novo generation of escape variant-specific CD8+ T-cell responses following cytotoxic T-lymphocyte escape in chronic human immunodeficiency virus type 1 infection. J Virol 2005; 79: 12952-12960. (Pubitemid 41433214)
28. Turnbull EL, Lopes AR, Jones NA, Cornforth D, Newton P, Aldam D et al. HIV-1 epitopespecific CD8+ T cell responses strongly associate with delayed disease progression cross-recognise epitope variants efficiently. J Immunol 2006; 176: 6130-6146.
29. Yu XG, Addo MM, Rosenberg ES, Rodriguez WR, Lee PK, Fitzpatrick CA et al. Consistent patterns in the development and immunodominance of human immunodeficiency virus type 1 (HIV-1)-specific CD8 T-cell responses following acute HIV-1 infection. J Virol 2002; 76: 8690-8701. (Pubitemid 34864064)
30. Brumme ZL, Brumme CJ, Carlson J, Streeck H, John M, Eichbaum Q et al. Marked epitope-and allele-specific differences in rates of mutation in human immunodeficiency virus type 1 (HIV-1) Gag, Pol, and Nef cytotoxic lymphocyte epitopes in acute/early HIV-1 infection. J Virol 2008; 82: 9216-9227.
31. Goulder PJ, Altfeld MA, Rosenberg ES, Nguyen T, Tang Y, Eldridge RL et al. Substantial differences in specificity of HIV-specific cytotoxic T cells in acute and chronic HIV infection. J Exp Med 2001; 193: 181-194.
32. Parker KC, Bednarek MA, Hull LK, Utz U, Cunningham B, Zweerink HJ et al. Sequence motifs important for peptide binding to the human MHC class 1 molecule, HLA-A2. J Immunol 1992; 149: 3580-3587.
33. Altfeld M, Addo MM, Eldridge RL, Yu XG, Thomas S, Khatri A et al. Vpr is preferentially targeted by CTL during HIV-1 infection. Immunol 2001; 167: 2743-2752. (Pubitemid 32768905)
34. Altfeld M, Allen TM, Yu XG, Johnston MN, Agrawal D, Korber BT et al. HIV-1 superinfection despite broad CD 8 T-cell responses containing replication of the primary virus. Nature 2002; 420: 434-439. (Pubitemid 35415656)
35. Leslie A, Price DA, Mkhize P, Bishop K, Rathod A, Day C et al. Differential selection pressure exerted on HIV by CTL targeting identical epitopes but restricted by distinct HLA alleles from the same HLA supertype. J Immunol 2006; 177: 4699-4708. (Pubitemid 44469803)
36. Cao J, McNevin J, Holte S, Fink L, Corey L, McElrath MJ. Comprehensive analysis of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon secreting CD8+ T cells in primary HIV-1 infection. J Virol 2003; 77: 6867-6878. (Pubitemid 36666880)
37. Bernardin F, Bernardin F, Kong D, Peddada L, Baxter-Lowe LA, Delwart E. Human immunodeficiency virus mutations during the first month of infection are preferentially found in known cytotoxic T-lymphocyte epitopes. J Virol 2005; 79: 11523-11528. (Pubitemid 41170695)
38. Kiepiela P, Leslie AJ, Honeyborne I, Ramduth D, Thobakgale C, Chetty S et al. Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. Nature 2004; 432: 769-774. (Pubitemid 39656298)
39. Allen TM, Altfeld M, Geer SC, Kalife EF, Moore C, O'Sullivan KM et al. Selective escape from CD8+ T-cell responses represents a major driving force of human immunodeficiency virus type-1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution. J Virol 2005; 79: 13239-13249. (Pubitemid 41508139)
40. Korber BC, Brander BF, Haynes R, Koup JP, Moore BD, Walker BD et al. HIV Molecular Immunology 2006/2007, Vol 1. Los Alamos National Laboratory, Theoretical Biology and Biophysics: Los Alamos, New Mexico.
41. Goulder PJ, Watkins DI. Impact of MHC class 1 diversity on immune control of immunodeficiency virus replication. Nat Rev Immunol 2008; 8: 619-630.
42. Harari A, Dutoit V, Cellerai C, Bart PA, Du Pasquier RA, Pantaleo G. Functional signatures of protective antiviral T-cell immunity in human virus infections. Immunol Rev 2006; 211: 236-254. (Pubitemid 43882976)
43. Fiebig EW, Wright DJ, Rawal BD, Garrett PE, Schumacher RT, Peddada L et al. Dynamics of HIV viremia and antibody seroconversion in plasma donors; implications for diagnosis and staging of primary HIV infection. AIDS 2003; 17: 1871-1879. (Pubitemid 37070272)
44. Inwoley A, Recordon-Pinson P, Dupuis M, Gaston J, Genete M, Minga A et al. Crossclade conservation of HIV type 1 Nef immunodominant regions recognised by CD8 T cells of HIV type 1 CRF02-AG-infected Ivorian (West Africa). AIDS Res Hum Retroviruses 2005; 21: 602-628.
45. Barbour JD, Grant RM. The role of viral fitness in HIV pathogenesis. Curr HIV/AIDS Rep 2005; 2: 29-34.
46. Kent SJ, Fernandez CS, Dale CJ, Davenport MP. Reversion of immune escape HIV variants upon transmission: insights into effective viral immunity. Trends Microbiol 2005; 13: 243-246. (Pubitemid 40779808)
47. Woodman Z, Williamson C. HIV molecular epidemiology: transmission and adaptation to human populations. Curr Opin HIV AIDS 2009; 4: 247-252.
48. Klenerman P, Zinkernagel RM. Original antigenic in impairs cytotoxic T lymphocyte responses to viruses bearing variant epitopes. Nature 1998; 394: 482-485. (Pubitemid 28373959)
49. Derby M, Alexander-Miller M, Tse R, Berzofsky J. High-avidity cytotoxic T lymphocyte clones with a disparity between functional avidity and MHC tetramer staining. J Immunol 2001; 166: 1690-1697.
50. Bennett MS, Ng HL, Dagarag M, Ali A, Yang OO. Epitope-dependant avidity thresholds for cytotoxic T-lymphocyte clearance of virus-infected cells. J Virol 2007; 81: 4973-4980. (Pubitemid 46744409)
51. Speiser DE, Kyburz D, Stubi U, Hengartner H, Zinkernagel RM. Discrepancy between in vitro measurable and in vivo virus neutralizing cytotoxic T cell reactivities. Low T cell receptor specificity and avidity sufficient for in vitro proliferation or cytotoxicity to peptide-coated target cells but not for in vivo protection. J Immunol 1992; 149: 972-980.
52. Alexander-Miller MA, Leggatt GR, Berzofsky JA. Selective expansion of high-or lowavidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy. Proc Natl Acad Sci USA 1996; 93: 4102-4107. (Pubitemid 26144250)
53. Messaoudi I, Guevara Patino JA, Dyall R, Le Maoult J, Nikolich-Zugich J. Direct link between MHC polymorphism, T cell avidity, and diversity in immune defense. Science 2002; 298: 1797-1800.
54. O'Connor DH, Allen TM, Vogel TU, Jing P, DeSouza IP, Dodds E et al. Acute phase cytotoxic T lymphocyte escape is a hallmark of simian immunodeficiency virus infection. Nat Med 2002; 8: 493-499. (Pubitemid 34546752)
55. Almeida JR, Price DA, Papagno L, Arkoub ZA, Sauce D, Bornstein E et al. Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover. J Exp Med 2007; 204: 2473-2485. (Pubitemid 47529331)
56. Belyakov IM, Kuznetsov VA, Kelsall B, Klinman D, Moniuszko M, Lemon M et al. Impact of vaccine-induced mucosal high-avidity CD8+ CTLs in delay of AIDS viral dissemination from mucosa. Blood 2006; 107: 3258-3264.
57. Price DA, Sewell AK, Dong T, Tan R, Goulder PJ, Rowland-Jones SL et al. Antigenspecific release of beta-chemokines by anti-HIV-1 cytotoxic T lymphocytes. Curr Biol 1998; 8: 355-358. (Pubitemid 28159124)
58. Betts MR, Price DA, Brenchley JM, Loré K, Guenaga FJ, Smed-Sorensen A et al. The functional profile of primary human antiviral CD8+ T cell effector and memory subsets of CD8+ T cells. J Immunol 2004; 172: 6407-6417. (Pubitemid 38621250)
59. Almeida JR, Sauce D, Price DA, Papagno L, Shin SY, Moris A et al. Antigen sensitivity is a major determinant of CD8+ T-cell polyfunctionality and HIV-suppressive activity. Blood 2009; 113: 6351-6360.
60. Dzutsev AH, Belyakov IM, Isakov DV, Margulies DH, Berzofsky JA. Avidity of CD8 T cells sharpens immunodominance. Int Immunol 2007; 19: 497-507. (Pubitemid 46523397)
61. Price DA, Brenchley JM, Ruff LE, Betts MR, Hill BJ, Roederer M et al. Avidity for antigen shapes clonal dominance in CD8+ T cell populations specific for persistent DNA viruses. J Exp Med 2005; 202: 1349-1361. (Pubitemid 41668738)
62. Appay V, Douek D, Price DA. CD8+ T cell efficacy in vaccination and disease. Nat Med 2008; 14: 623-628. (Pubitemid 351809548)
63. Jenkins MR, La Gruta NL, Doherty PC, Trapani JA, Turner SJ, Waterhouse NJ. Visualizing CTL activity for different CD8+ effector T cells supports the idea that lower TCR/epitope avidity may be advantageous for target cell killing. Cell Death Differ 2009; 16: 537-542.
64. Harari A, Cellerai C, Enders FB, Köstler J, Codarri L, Tapia G et al. Skewed association of polyfunctional antigen-specific CD8 T cell populations with HLA-B genotype. Proc Natl Acad Sci USA 2007; 104: 16233-16238. (Pubitemid 350099390)
65. Feeney ME, Tang Y, Pfafferott K, Roosevelt KA, Draenert R, Trocha A et al. HIV-1 viral escape in infancy followed by emergence of a variant-specific CTL response. J Immunol 2005; 174: 7524-7530. (Pubitemid 40806255)
66. Ueno T, Idegami Y, Motozono C, Oka S, Takiguchi M. Altering effects of antigenic variations in HIV-1 on antiviral effectiveness of HIV-specific CTLs. J Immunol 2006; 178: 5513-5523. (Pubitemid 46674346)
67. Draenert R, Verrill CL, Tang Y, Allen TM, Wurcel AG, Boczanowski M et al. Persistent recognition of autologous virus by high-avidity CD8 T cells in chronic, progressive human immunodeficiency virus type 1 infection. J Virol 2004; 78: 630-641. (Pubitemid 38067584)
68. Addo MM, Yu XG, Rathod A, Cohen D, Eldridge RL, Strick D et al. Comprehensive epitope analysis of human immunodeficiency virus type-1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrated broadly directed responses, but no correlation to viral load. J Virol 2003; 77: 2081-2092. (Pubitemid 36110021)
69. De Rosa R, Fernandez CS, Smith MZ, Batten CJ, Alcantara S, Peut V et al. Control of viremia and prevention of AIDS following immunotherapy of SIV-infected Macaques with peptide-pulsed blood. PLoS Pathog 2008; 4: e1000055.
70. Kiepiela P, Ngumbela K, Thobakgale C, Ramduth D, Honeyborne I, Moodley E et al. CD8+ T-cell responses to different HIV proteins have discordant associations with viral load. Nat Med 2007; 13: 46-53. (Pubitemid 46067385)
71. Fischer W, Perkins S, Theiler J, Bhattacharya T, Yusim K, Funkhouser R et al. Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants. Nat Med 2007; 13: 100-106. (Pubitemid 46067393)
72. Korber BT, Letvin NL, Haynes BF. T cell vaccines for Human immunodeficiency virus, the virus with a thousand faces. J Virol 2009; 83: 8300-8314.
73. Pohling J, Zipperlen K, Hollett NA, Gallant ME, Grant MD. Human immunodeficiency virus type 1-specific CD8+ T cell subset abnormalities in chronic infection persist through effective antiretroviral therapy. BMC Infect Dis 2010; 10: 129.
74. Casazza JP, Betts MR, Picker LJ, Koup RA. Decay kinetics of human immunodeficiency virus-specific CD8+ T cells in peripheral blood after initiation of highly active antiretroviral therapy. J Virol 2001; 75: 6508-6516. (Pubitemid 32578170)
75. Horton H, Frank I, Baydo R, Jalbert E, Penn J, Wilson S et al. Preservation of T cell proliferation restricted by protective HLA alleles is critical for immune control of HIV-1 infection. J Immunol 2006; 177: 7406-7415. (Pubitemid 44715111)
76. Kroger CJ, Amoah S, Alexander-Miller MA. Cutting edge: dendritic cells prime a high avidity CTL response independent of the level of presented antigen. J Immunol 2008; 180: 5784-5788.
77. Keane NM, Price P, Stone SF, John M, Murray RJ, French MA. Assessment of immune function by lymphoproliferation underestimates lymphocyte functional capacity in HIV patients treated with highly active antiretroviral therapy. AIDS Res Hum Retroviruses 2000; 16: 1991-1996. (Pubitemid 32048457)
78. Foley BA, De Santis D, Van Beelen E, Lathbury LJ, Christiansen FJ, Witt CS. The reactivity of Bw4+ HLA-B and HLA-A alleles with KIR3DL1: implications for patient and donor suitability for haploidentical stem cell transplantations. Blood 2009; 112: 435-443.
79. Decrion AZ, Varin A, Drobacheff C, Estavoyer JM, Herbein G. A subset of functional effector-memory CD8+ T lymphocytes in human immunodeficiency virus-infected patients. Immunology 2007; 121: 405-415. (Pubitemid 46817362)